Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-10

Clinical Trial Update: Botulinum Toxin Injections for Oral Neuropathic Pain [Phase 3]

View source ↗

Summary

Phase 3 trial investigating botulinum toxin injections for oral neuropathic pain due to trigeminal neuropathy (traumatic). Study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin injections (botulinum toxin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Trigeminal Neuropathy, Traumatic | Phase 3 | Status: COMPLETED